ANNA DODD: Open Payments
NPI 1083293914 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,879 in 70 payments from 13 companies in 2025. Trend: 2023 $1,961 · 2024 $1,917 · 2025 $1,879
Food & beverage: $1,879
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $420 |
| Caris MPI, Inc. | 11 | $343 |
| ABBVIE INC. | 9 | $272 |
| Merck Sharp & Dohme LLC | 9 | $250 |
| Eisai Inc. | 7 | $219 |
| AstraZeneca Pharmaceuticals LP | 7 | $148 |
| Verastem, Inc. | 2 | $68 |
| Astellas Pharma US Inc | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Dilon Technologies, Inc. | 1 | $28 |
Products named: JEMPERLI, MI CANCER SEEK, ELAHERE, LYNPARZA, Lenvima, KEYTRUDA, AVMAPKI FAKZYNJA CO-PACK, KEYTRUDA QLEX.
Industry payments across TN — which companies pay providers there.
